X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 25,805 | 29,304 | 25,577 | 20,154 | 20,570 |
| Operating Income | -25,805 | -29,304 | -25,577 | -20,154 | -20,570 |
| Interest Expense | 1,148 | 1,109 | 1,144 | 1,018 | 918 |
| Other Income | -28,744 | 6,397 | -2,369 | -427 | 280 |
| Pre-tax Income | -55,697 | -24,016 | -29,090 | -21,599 | -21,208 |
| Income Tax | 15 | 4 | 14 | -13 | 4 |
| Net Income Continuous | -55,712 | -24,020 | -29,104 | -21,586 | -21,212 |
| Net Income | $-55,712 | $-24,020 | $-29,104 | $-21,586 | $-21,212 |
| EPS Basic Total Ops | -9.91 | -4.80 | 1.80 | -7.81 | -18.02 |
| EPS Basic Continuous Ops | -9.92 | -4.94 | 0.94 | -7.79 | -17.98 |
| EPS Diluted Total Ops | -9.91 | -4.80 | 1.80 | -7.81 | -18.02 |
| EPS Diluted Continuous Ops | -9.92 | -4.94 | 0.94 | -7.79 | -17.98 |
| EBITDA(a) | $-25,679 | $-29,177 | $-25,453 | $-20,030 | $-20,438 |